Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...
National Institute of Allergy and Infectious Diseases (NIAID), July 24, 2017 A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported today at the 9th IAS Conference on HIV Science in Paris. This case appears to be the...
The Age, Published APRIL 2 2017 Doctors are on the cusp of launching the first new male contraceptive in more than a century. But rather than a Big Pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval...
SAMESH, April 2017 There has been a lot of community interest in the PrEPX-SA trial. You are invited to an upcoming community forum where a distinguished panel of experts and community members involved in the field will discuss PrEP, a powerful new tool to prevent HIV and the upcoming PrEPX-SA study. The panel will include: Associate Professor Edwina Wright (Alfred Health) Professor Steve...
New Scientist, 22 February 2017
FIVE people with HIV are currently free of detectable virus – and daily drugs – thanks to a new vaccine-based therapy.
Although it is early days, one participant has been drug-free for seven months.
Read more here
Health Consumers Alliance of South Australia, 2017 The Department for Health and Ageing is seeking feedback on a proposed patient access pathway for medical cannabis in South Australia. A discussion paper has been released which proposes a patient access pathway including amendments to South Australian controlled substances legislation, to ensure national consistency towards safe and appropriate...